ロード中...
Evaluation of cerebrospinal fluid phosphorylated tau(231) as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia
BACKGROUND: The diagnosis of either Alzheimer's disease (AD) or vascular dementia (VaD) is still largely based on clinical guidelines and exclusion of other diseases that may lead to dementia. AIMS: In this study, we assessed whether the use of sensitive and specific biomarkers such as phosphor...
保存先:
| 出版年: | CNS Neurosci Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047904/ https://ncbi.nlm.nih.gov/pubmed/29453935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12814 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|